STS Medical, a company based in Israel, won FDA clearance for its sole product, the S.T.Stent sinus stent. The composite device is indicated for treatment of chronic sinusitis, as part of Functional Endoscopic Sinus Surgery (FESS), to help keep the sinus cavity open post surgery. It can also be used to address nose job failures, chronic allergic rhinitis, as an option over sinuplasty.
The device is flexible and conforms to the sinus cavity of the patient it’s placed in, relying on a balloon delivery system for expansion. Once positioned, it’s designed to anchor in place and not move around. It is then left within the lumen for up to four weeks, allowing the surrounding tissue to heal. The materials it’s made of are biocompatible and shouldn’t irritate the patient. Removal of the device is an in-office procedure that doesn’t require anesthesia.
Link: S.T. Stent homepage…